New York State Common Retirement Fund Lava Therapeutics Nv Transaction History

New York State Common Retirement Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$5.5 - $11.0 $105,248 - $210,496	-19,136 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$10.8 - $16.0 $73,828 - $109,376	-6,836 Reduced 26.32%	19,136 $208,000
Q1 2021 May 11, 2021	BUY	$12.5 - $15.19 $324,650 - $394,514	25,972 New	25,972 $395,000

3.61M

32.9K

500

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $26.8M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.